Pentixapharm scores $22M in Frankfurt IPO to advance clinical-stage radiopharmaceuticals

Pentixapharm scores $22M in Frankfurt IPO to advance clinical-stage radiopharmaceuticals jwaldron Thu, 10/03/2024 - 10:17